To analyze L-carnitine-attributed effects, a propensity score to determine the probability for each patient to be treated with L-carnitine was constructed and used in the multivariate analysis
Close monitoring and adjustments may be necessary to optimize treatment outcomes
Berberine is not FDA-approved for weight loss or for treating medical conditions
The European Medicines Agencys Pharmacovigilance Risk Assessment Committee also concluded that NAION should be listed as a very rare side effect of semaglutide medications after reviewing clinical trials, post-marketing surveillance, non-clinical data, and published medical literature
Zillen D, Beugeling M, Hinrichs WLJ, Frijlink HW, Grasmeijer F (2021) Natural and bioinspired excipients for dry powder inhalation formulations
Before undergoing the test, fasting may be required